VeriSIM Life September Newsletter
VeriSIM Life
Introducing BIOiSIM, an AI-driven drug development engine designed to de-risk and inform R&D decision-making.
From CEO & Founder Dr. Jo Varshney being named to San Francisco Business Times’ Most Influential Women list to prepping for upcoming events and more, VeriSIM Life has had an eventful month! Reach out to our team to learn more about how BIOiSIM could fit into your strategy for de-risking R&D and getting life-saving drugs to patients faster.
Dr. Jo Varshney Named to List of Most Influential Women in Bay Area Business from the San Francisco Business Times
We were thrilled to announce this month that Founder and CEO, Dr. Jo Varshney, was named to the San Francisco Business Times' 2024 list of Most Influential Women in Bay Area Business. Dr. Varshney was competitively selected from more than 400 nominees to be honored with this prestigious award for her successful leadership at VeriSIM Life and innovation in the biopharma industry. "This recognition from the San Francisco Business Times as one of the Most Influential Women in Bay Area Business is a profound honor," said Dr. Varshney. "As a Bay Area resident, I am proud to have built VeriSIM Life in such an inspiring community of strong, female leaders and innovators."
Blog – Enhancing FDA-Approved AI/ML Methods: VeriSIM Life's Comprehensive Approach to Drug Development and Patient Selection
The FDA's development and use of an AI/ML-based scoring rule for patient selection in the Emergency Use Authorization (EUA) of anakinra to treat COVID-19 marks a significant milestone in the integration of advanced technologies in drug development and patient care. This blog post explores the FDA's approach, its requirements, and how VeriSIM Life's cutting-edge techniques offer an even more informative and powerful methodology for drug development and patient selection.
Recommended by LinkedIn
Dr. Varshney at Upcoming EmpowerHer Women’s Entrepreneurial Event
On September 26th, Dr. Varshney will join the AAPS EmpowerHer Workshop: Unleashing the Entrepreneurial Spirit in Women. This career development session aims to “shed light on these challenges, provide real life stories from experienced entrepreneurs, and inspire attendees to fearlessly pursue their entrepreneurial dreams.” In addition to that, don’t miss Dr. Varshney at ILMAC in Switzerland. Other upcoming events that will be attended by our Head of Biosimulations, Dr. Divesh Bhatt include the Annual AIT Conference, plus AAPS PharmSci 360 in October. Additionally, Dr. Szczepan Baran will co-host a presentation with Pfizer at the Digital Health & AI Innovation Summit.
What We’re Reading
Pink Sheet Regulatory published a compelling interview with CEO & Founder Dr. Jo Varshney on the topic of animal experimentation, and changes in regulatory requirements around it (paywalled.) “Having a platform like BIOiSIM gives (companies) more data to do the right animal experiments and also the necessary animal experiments,” Dr. Varshney states in the article.